 Roxadustat

Roxadustat (, also known as FG-4592, ASP1517 and AZD9941) is a drug (Evrenzo® in Japan) which acts as a HIF prolyl-hydroxylase inhibitor and thereby increases endogenous production of erythropoietin, which stimulates production of hemoglobin and red blood cells.It was investigated in clinical trials for the treatment of anemia secondary to chronic kidney disease.